241 related articles for article (PubMed ID: 36399356)
1. Detecting Liver Cancer Using Cell-Free DNA Fragmentomes.
Foda ZH; Annapragada AV; Boyapati K; Bruhm DC; Vulpescu NA; Medina JE; Mathios D; Cristiano S; Niknafs N; Luu HT; Goggins MG; Anders RA; Sun J; Meta SH; Thomas DL; Kirk GD; Adleff V; Phallen J; Scharpf RB; Kim AK; Velculescu VE
Cancer Discov; 2023 Mar; 13(3):616-631. PubMed ID: 36399356
[TBL] [Abstract][Full Text] [Related]
2. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma.
Luo B; Ma F; Liu H; Hu J; Rao L; Liu C; Jiang Y; Kuangzeng S; Lin X; Wang C; Lei Y; Si Z; Chen G; Zhou N; Liang C; Jiang F; Liu F; Dai W; Liu W; Gao Y; Li Z; Li X; Zhou G; Li B; Zhang Z; Nian W; Luo L; Liu X
BMC Med; 2022 Jan; 20(1):8. PubMed ID: 35027051
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection.
Wang P; Song Q; Ren J; Zhang W; Wang Y; Zhou L; Wang D; Chen K; Jiang L; Zhang B; Chen W; Qu C; Zhao H; Jiao Y
Sci Transl Med; 2022 Nov; 14(672):eabp8704. PubMed ID: 36417488
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
[TBL] [Abstract][Full Text] [Related]
7. Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics.
Jiao J; Sanchez JI; Thompson EJ; Mao X; McCormick JB; Fisher-Hoch SP; Futreal PA; Zhang J; Beretta L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299031
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
[TBL] [Abstract][Full Text] [Related]
9. Detection and monitoring of HBV-related hepatocellular carcinoma from plasma cfDNA fragmentation profiles.
Sun X; Feng W; Cui P; Ruan R; Ma W; Han Z; Sun J; Pan Y; Zhu J; Zhong X; Li J; Ma M; Hu R; Lv M; Huang Q; Zhang W; Feng M; Zhuang X; Huang B; Zhou X
Genomics; 2022 Nov; 114(6):110502. PubMed ID: 36220554
[TBL] [Abstract][Full Text] [Related]
10. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.
Deng Z; Ji Y; Han B; Tan Z; Ren Y; Gao J; Chen N; Ma C; Zhang Y; Yao Y; Lu H; Huang H; Xu M; Chen L; Zheng L; Gu J; Xiong D; Zhao J; Gu J; Chen Z; Wang K
Genome Med; 2023 Nov; 15(1):93. PubMed ID: 37936230
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
[TBL] [Abstract][Full Text] [Related]
12. Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures.
Fan R; Chen L; Zhao S; Yang H; Li Z; Qian Y; Ma H; Liu X; Wang C; Liang X; Bai J; Xie J; Fan X; Xie Q; Hao X; Wang C; Yang S; Gao Y; Bai H; Dou X; Liu J; Wu L; Jiang G; Xia Q; Zheng D; Rao H; Xia J; Shang J; Gao P; Xie D; Yu Y; Yang Y; Gao H; Liu Y; Sun A; Jiang Y; Yu Y; Niu J; Sun J; Wang H; Hou J
J Hepatol; 2023 Oct; 79(4):933-944. PubMed ID: 37302583
[TBL] [Abstract][Full Text] [Related]
13. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
[TBL] [Abstract][Full Text] [Related]
15. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
Jiang P; Chan KCA; Lo YMD
J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
[TBL] [Abstract][Full Text] [Related]
16. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
Jeepalyam S; Sheel A; Ejaz A; Miller E; Manne A
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762533
[TBL] [Abstract][Full Text] [Related]
17. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection.
Jin C; Liu X; Zheng W; Su L; Liu Y; Guo X; Gu X; Li H; Xu B; Wang G; Yu J; Zhang Q; Bao D; Wan S; Xu F; Lai X; Liu J; Xing J
Mol Oncol; 2021 Sep; 15(9):2377-2389. PubMed ID: 34133846
[TBL] [Abstract][Full Text] [Related]
18. Multiple-level copy number variations in cell-free DNA for prognostic prediction of HCC with radical treatments.
Wang Y; Zhou K; Wang X; Liu Y; Guo D; Bian Z; Su L; Liu K; Gu X; Guo X; Wang L; Zhang H; Tao K; Xing J
Cancer Sci; 2021 Nov; 112(11):4772-4784. PubMed ID: 34490703
[TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics.
Zhang X; Wang Z; Tang W; Wang X; Liu R; Bao H; Chen X; Wei Y; Wu S; Bao H; Wu X; Shao Y; Fan J; Zhou J
Hepatology; 2022 Aug; 76(2):317-329. PubMed ID: 34954829
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
